Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Boothby

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|March 6, 2003
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptorLi Yang, Noboru Yamagata, Rajwardhan Yadav, et al.
Blood|February 28, 2013
Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell inductionBrian R Rosborough, Dàlia Raïch-Regué, Benjamin M Matta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 responseRadiah A Corn, Mark A Aronica, Fuping Zhang, et al.
Cancer Research|July 28, 2012
INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcomaJinming Yang, Sara Kantrow, Jiqing Sai, et al.
Journal of the National Cancer Institute|July 26, 2012
Effects of cancer-associated EPHA3 mutations on lung cancerGuanglei Zhuang, Wenqiang Song, Katherine Amato, et al.
The Journal of Experimental Medicine|October 15, 2014
microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cellsAntoine Marcais, Rory Blevins, Johannes Graumann, et al.
The Journal of Clinical Investigation|May 18, 2023
Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN productionShyamala Thirunavukkarasu, Mushtaq Ahmed, Bruce A Rosa, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
Molecular and Cellular Biology|August 28, 2013
Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signalingVictoria A McGuire, Alexander Gray, Claire E Monk, et al.
Nature Communications|November 1, 2016
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylationHiroshi Iwata, Claudia Goettsch, Amitabh Sharma, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|March 6, 2003
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptorLi Yang, Noboru Yamagata, Rajwardhan Yadav, et al.
Blood|February 28, 2013
Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell inductionBrian R Rosborough, Dàlia Raïch-Regué, Benjamin M Matta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 responseRadiah A Corn, Mark A Aronica, Fuping Zhang, et al.
Cancer Research|July 28, 2012
INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcomaJinming Yang, Sara Kantrow, Jiqing Sai, et al.
Journal of the National Cancer Institute|July 26, 2012
Effects of cancer-associated EPHA3 mutations on lung cancerGuanglei Zhuang, Wenqiang Song, Katherine Amato, et al.
The Journal of Experimental Medicine|October 15, 2014
microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cellsAntoine Marcais, Rory Blevins, Johannes Graumann, et al.
The Journal of Clinical Investigation|May 18, 2023
Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN productionShyamala Thirunavukkarasu, Mushtaq Ahmed, Bruce A Rosa, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
Molecular and Cellular Biology|August 28, 2013
Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signalingVictoria A McGuire, Alexander Gray, Claire E Monk, et al.
Nature Communications|November 1, 2016
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylationHiroshi Iwata, Claudia Goettsch, Amitabh Sharma, et al.
Pageof 6